Claim OwnershipListen to Gynecologic Oncology
Subscribed: 31Played: 216
Subscribe
© 2023 Elsevier Ltd.
Description
Listen to the latest news from the experts in your field.
54 Episodes
Reverse
Editor’s Choice Papers: What's in it for me?: A value assessment of gynecologic cancer clinical trials for Black women Editorial: Achieving diversity in clinical trial enrollment by reducing burden and increasing value: A patient-centered approachHosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic Oncology Featuring: Ann Oluloro, MD, MPH, University of WashingtonEloise Chapman-Davis, MD, Weill Cornell Medicine
Editor’s Choice: Integration of self-hypnosis in an enhanced recovery after surgery program in gynecologic oncology – A prospective randomized trial
Editorial: Relax - It’s evidence-based: The role of hypnosis in managing post-operative symptoms
Editor’s Choice: TROP2 expression and therapeutic targeting in uterine carcinosarcoma
Editorial: The search for new therapeutic options for uterine carcinosarcoma
Editor’s Choice: STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs
Editorial: Diverting ileostomy: An ounce of prevention, but when?
Editor’s Choice: Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
Editorial: Implications of the Platinum-Free Interval in Endometrial Cancer: A Legacy Worth Leaving Behind?
Hosted by:Warner Huh, MD, Deputy Editor of Gynecologic OncologyFeaturing: Paulina Haight, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, OH, United States of AmericaRamez N. Eskander, MD, UC San Diego School of Medicine, Moores Cancer Center at UC San Diego Health, San Diego, CA
Editor’s Choice: Primary prevention of post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole: A single-dose prophylactic actinomycin D, associated with uterine evacuation - a long retrospective cohort study
Editorial: Prevention of Gestational Trophoblastic Neoplasia with Actinomycin -D at the time of evacuation: A Matter of Routine Practice or Reserve for Special Circumstances?
Editor’s Choice: Clinical trial enrollment during first course of gynecologic cancer treatment and survival
Editorial: Clinical trials are not the solution to inequities in cancer care
Editor’s Choice: Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma
Editorial: Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma
Hosted by:Warner Huh, MD, Deputy Editor of Gynecologic OncologyFeaturing: Tullia Rushton, MD
Beryl L. Manning-Geist, MD
Editor’s Choice: The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study
Editorial: Hormonal maintenance therapy for advance low grade serous ovarian carcinoma appears to be of benefit – That's a relief!
Editor’s Choice: Implementation of a financial navigation program in gynecologic oncology
Editorial: Financial toxicity: moving from describing the problem toward developing interventions
Hosted by:Diane Yamada, MDFeaturing: Katharine M. Esselen, MDMargaret Liang, MD
Editor’s choice: The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma
Editorial: Is substantial lymphovascular space invasion in FIGO stage I endometrial carcinoma ready for primetime in deciding adjuvant treatment?
Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic OncologyFeaturing: Mohamed Elshaikh, MDBeriwal Sushil MD
Editor’s choice: Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva
Editorial: Optimizing and harmonizing lymph node dissection and radiotherapy in advanced vulvar cancer
Hosted by: Dr David Gaffney, MD, PhD, Associate Editor of Gynecologic Oncology
Featuring: Dr Lilian T. Gien, MD, MSc, FRCSC, University of Toronto, Canada
Dr Brenna Swift, MD, FRCSC, MSc, MASc, University of Toronto, Canada
Dr Scott Glaser, MD, City of Hope, USA
Editor’s choice: Shifting trends and sicker patients: Reassessing hysterectomy performed for benign indications by gynecologic oncologists
Editorial: Who you gonna call?
Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic Oncology
Featuring:M. Dwight Chen, MD, Palo Alto Foundation Medical Group/Sutter HealthConnor C. Wang, MD, Northwestern University Feinberg School of MedicineEmma Barber, MD, MS, Northwestern University Feinberg School of Medicine
Reviews: 2023 changes to FIGO endometrial cancer staging: Counterpoint; 2023 FIGO staging system for endometrial cancer: The evolution of the revolution
Editorial: 2023 FIGO staging for endometrial cancer, a look at both sides of the coin
Hosted by: Sean Dowdy, MD, FACS, FACOG, Associate Editor of Gynecologic Oncology
Featuring: Dr. Alexander Olawaiye, MD, University of Pittsburgh School of Medicine, USA
Dr. David Gaffney, MD-PhD, University of Utah, USA
Dr. Mario Leitao, Jr., MD, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, USA
Editor’s Choice Paper:Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study
Editorial:Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement
Hosted by:Gregg Nelson, MD, Social Media Editor of Gynecologic OncologyFeaturing:Sarah M. Bjørnholt, MD, Aarhus University Hospital, DenmarkSean Dowdy, MD, Mayo Clinic, USA
Editor’s Choice Paper: Experiences of patients with peritoneal carcinomatosis-related complex care needs and their caregivers Editorial:The importance of family-focused care in the setting of advanced gynecological cancersHosted by:Sean Dowdy, MD, Associate Editor of Gynecologic OncologyFeaturing:Rachel A. Pozzar, PhD, RN, Dana Farber Cancer Institute and Harvard Medical SchoolAllison J. Applebaum, PhD, Caregivers Clinic, Memorial Sloan Kettering Cancer Center
Editor’s Choice Paper: Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma Editorial:What's in your “lunchbox”? Sandwich versus sequential chemotherapy and irradiation for advanced endometrial cancerHosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic OncologyFeaturing:Joyce Barlin, MD, Women’s Cancer Care Associates & Albany Medical CollegeGretchen Glaser, MD, Mayo Clinic John Weroha, MD, Mayo Clinic
Editor’s Choice Paper: Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients Editorial:How does mobile health engagement technology help gynecologic oncology patients recover from surgery, affect health equity, and impact healthcare costs?Hosted by:Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic OncologyFeaturing:Teresa K.L. Boitano, MD, University of Alabama at BirminghamKevin M. Elias, MD, FACOG, FACS, Brigham and Women’s Hospital
Editor’s Choice Paper: Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer Hosted by:Ursula Matulonis, MD, Associate Editor of Gynecologic OncologyFeaturing:Kathleen N. Moore, MD, GOG-F and Stephenson Cancer Center at the University of Oklahoma Health Sciences Center
Editor’s Choice Paper: Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis? Editorial: Universal thromboprophylaxis in ovarian cancer patients before and after surgery? Hosted by:David E. Cohn, MD, MBA, FACHE, Editor-in-Chief of Gynecologic OncologyFeaturing:Amanika Kumar, MD, Mayo Clinic Laura Havrilesky, MD, Duke University
Comments
Download from Google Play
Download from App Store
United States